Concepedia

M. Stoltz

MS

11

Publications

744

Citations

11

H-Index

1978

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Hormel (United States)

MRIGlobal

M. Stoltz is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, pharmacology, and metabolism.

ORCID

Top concepts

Publications per year

1978–2024

11

Publications

11

Phase II Study of the Cyclin-Dependent Kinase Inhibitor Flavopiridol Administered to Patients With Advanced Gastric Carcinoma

Gary K. Schwartz, David H. Ilson, Leonard B. Saltz et al. · Journal of Clinical Oncology · 2001 · 198 citations

Phase I Study of the Cyclin-Dependent Kinase Inhibitor Flavopiridol in Combination With Paclitaxel in Patients With Advanced Solid Tumors

Gary K. Schwartz, Eileen M. O’Reilly, David H. Ilson et al. · Journal of Clinical Oncology · 2002 · 156 citations

Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers

Tanya L. Russell, M. Stoltz, Scott J. Weir · Clinical Pharmacology & Therapeutics · 1998 · 127 citations

Absorption, disposition and metabolism of di‐isononyl phthalate (DINP) in F‐344 rats

R. H. McKee, Mohamad El-Hawari, M. Stoltz et al. · Journal of Applied Toxicology · 2002 · 71 citations

, , +16

A pilot pharmacokinetic study of oral azacitidine

Guillermo Garcia‐Manero, M. Stoltz, M. Renee Ward et al. · Leukemia · 2008 · 68 citations

, , +4

Rows per page

1–5 of 11